Alto Neuroscience vs Zynerba Pharmaceuticals
Alto Neuroscience vs Zynerba Pharmaceuticals, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alto Neuroscience is on 43/100 and Zynerba Pharmaceuticals on 38/100.
Where each one leads
Alto Neuroscience
- our overall score: 43/100 against 38/100
- agent readiness: 48/100 against 22/100
Zynerba Pharmaceuticals
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Alto Neuroscience | Zynerba Pharmaceuticals |
|---|---|---|
| What it is | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. | Pharmaceutical company developing transdermal cannabinoid therapeutics for behavioral and emotional conditions. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, Drug Discovery, Clinical Trials |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2019 | 2007 |
| Headquarters | Los Altos, United States | Wayne, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Alto Neuroscience | Zynerba Pharmaceuticals |
|---|---|---|
| Employees | 86 | Not published |
| Total funding | $370M | Not published |
| Latest round | Registered Direct Offering | Not published |
| LinkedIn followers | 24,482 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alto Neuroscience | Zynerba Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 38/100 |
| Traction | 59/100 | Not published |
| Team | Not published | 30/100 |
| Community | 13/100 | 15/100 |
| Search visibility | 35/100 | 2/100 |
| Quality | 45/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alto Neuroscience | Zynerba Pharmaceuticals |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Tag Manager |
Alto Neuroscience vs Zynerba Pharmaceuticals: common questions
Which is better, Alto Neuroscience or Zynerba Pharmaceuticals?
On our 0-100 score Alto Neuroscience rates higher (43/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Alto Neuroscience and Zynerba Pharmaceuticals compare on the numbers?
Alto Neuroscience leads on our overall score (43/100 against 38/100), agent readiness (48/100 against 22/100).
Read the full Alto Neuroscience review and pricing or the Zynerba Pharmaceuticals review and pricing. You can also browse other Alto Neuroscience alternatives we track.